Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength
Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a COOH-terminal extension called the E-peptide. Alternative splicing in the rodent produces two isoforms, IA and IB, where the mature IGF-I in both isofor...
Saved in:
Published in | American journal of physiology: endocrinology and metabolism Vol. 306; no. 8; pp. E965 - E974 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Physiological Society
15.04.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a COOH-terminal extension called the E-peptide. Alternative splicing in the rodent produces two isoforms, IA and IB, where the mature IGF-I in both isoforms is identical yet the E-peptides, EA and EB, share less than 50% homology. Recent in vitro studies show that the E-peptides can enhance IGF-I signaling, leading to increased myoblast cell proliferation and migration. To determine the significance of these actions in vivo and to evaluate if they are physiologically beneficial, EA and EB were expressed in murine skeletal muscle via viral vectors. The viral constructs ensured production of E-peptides without the influence of additional IGF-I through an inactivating mutation in mature IGF-I. E-peptide expression altered ERK1/2 and Akt phosphorylation and increased satellite cell proliferation. EB expression resulted in significant muscle hypertrophy that was IGF-I receptor dependent. However, the increased mass was associated with a loss of muscle strength. EA and EB have similar effects in skeletal muscle signaling and on satellite cells, but EB is more potent at increasing muscle mass. Although sustained EB expression may drive hypertrophy, there are significant physiological consequences for muscle. |
---|---|
AbstractList | Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a COOH-terminal extension called the E-peptide. Alternative splicing in the rodent produces two isoforms, IA and IB, where the mature IGF-I in both isoforms is identical yet the E-peptides, EA and EB, share less than 50% homology. Recent in vitro studies show that the E-peptides can enhance IGF-I signaling, leading to increased myoblast cell proliferation and migration. To determine the significance of these actions in vivo and to evaluate if they are physiologically beneficial, EA and EB were expressed in murine skeletal muscle via viral vectors. The viral constructs ensured production of E-peptides without the influence of additional IGF-I through an inactivating mutation in mature IGF-I. E-peptide expression altered ERK1/2 and Akt phosphorylation and increased satellite cell proliferation. EB expression resulted in significant muscle hypertrophy that was IGF-I receptor dependent. However, the increased mass was associated with a loss of muscle strength. EA and EB have similar effects in skeletal muscle signaling and on satellite cells, but EB is more potent at increasing muscle mass. Although sustained EB expression may drive hypertrophy, there are significant physiological consequences for muscle. [PUBLICATION ABSTRACT] Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a COOH-terminal extension called the E-peptide. Alternative splicing in the rodent produces two isoforms, IA and IB, where the mature IGF-I in both isoforms is identical yet the E-peptides, EA and EB, share less than 50% homology. Recent in vitro studies show that the E-peptides can enhance IGF-I signaling, leading to increased myoblast cell proliferation and migration. To determine the significance of these actions in vivo and to evaluate if they are physiologically beneficial, EA and EB were expressed in murine skeletal muscle via viral vectors. The viral constructs ensured production of E-peptides without the influence of additional IGF-I through an inactivating mutation in mature IGF-I. E-peptide expression altered ERK1/2 and Akt phosphorylation and increased satellite cell proliferation. EB expression resulted in significant muscle hypertrophy that was IGF-I receptor dependent. However, the increased mass was associated with a loss of muscle strength. EA and EB have similar effects in skeletal muscle signaling and on satellite cells, but EB is more potent at increasing muscle mass. Although sustained EB expression may drive hypertrophy, there are significant physiological consequences for muscle. |
Author | Brisson, Becky K Spinazzola, Janelle Barton, Elisabeth R Park, SooHyun |
Author_xml | – sequence: 1 givenname: Becky K surname: Brisson fullname: Brisson, Becky K organization: Department of Anatomy and Cell Biology, School of Dental Medicine, and Pennsylvania Muscle Institute, University of Pennsylvania, Philadelphia, Pennsylvania – sequence: 2 givenname: Janelle surname: Spinazzola fullname: Spinazzola, Janelle – sequence: 3 givenname: SooHyun surname: Park fullname: Park, SooHyun – sequence: 4 givenname: Elisabeth R surname: Barton fullname: Barton, Elisabeth R |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24569593$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkk9vFCEYh4mpsdvqF_BgSLx4mZX_M1xMTNNqkyZe1CsB5t3d2c7CCIzab1_Gro16Eg6QvA9PeOF3hk5CDIDQS0rWlEr21u4nCH1ckzq6NSNUPEGrWmANlVKeoBWhmje0E_oUneW8r1grBXuGTpmQSkvNV-ju65DsiOHnlCDnIQYcN3gIeR6H0IzDLeBtij_KDm-sLzHha3zZTDCVoYdcOZ_A5rrLtzBCqaLDnP0I-GBzxm4u2BZcdrD4IWRY5LkkCNuye46ebuyY4cVxPUdfri4_X3xsbj59uL54f9N4oXhplLWOeODUtcJT5uoEz9yGKgcd75VV3pO26xioTvteKeqkIsIJp0UvW8fP0bsH7zS7A_QeQqkdmykNB5vuTLSD-bsShp3Zxu-G6063glXBm6MgxW8z5GIOQ_YwjjZAnLOhkotOEs7Ff6C05VoTtqCv_0H3cU6hvsRCacUIJ7RS7IHyKeacYPN4b0rMEgJzDIH5FQKzhKAeevVnx49Hfv86vweWzLMz |
CODEN | AJPMD9 |
CitedBy_id | crossref_primary_10_3724_abbs_2023086 crossref_primary_10_1017_S0954422423000124 crossref_primary_10_2147_IJGM_S301141 crossref_primary_10_3389_fphys_2018_00999 crossref_primary_10_1016_j_biomaterials_2014_12_050 crossref_primary_10_1016_j_ghir_2016_11_001 crossref_primary_10_1007_s00424_014_1645_5 crossref_primary_10_1016_j_ghir_2014_06_003 crossref_primary_10_1080_10408398_2021_1986466 crossref_primary_10_1111_acel_12954 crossref_primary_10_1152_ajpregu_00230_2015 crossref_primary_10_1016_j_bone_2015_04_036 crossref_primary_10_1002_mus_26641 crossref_primary_10_3389_fphys_2022_1028345 crossref_primary_10_36803_ijpmr_v11i01_328 crossref_primary_10_1016_j_yexcr_2017_06_015 crossref_primary_10_3390_ijms21196995 |
Cites_doi | 10.1073/pnas.0604893104 10.1172/JCI0213503 10.1210/jcem-65-5-868 10.1016/j.febslet.2007.05.030 10.1210/mend-1-3-243 10.1101/gad.908001 10.1096/fj.11-192195 10.1038/84839 10.1152/jappl.1998.84.5.1716 10.1249/00005768-199006000-00006 10.1113/jphysiol.2011.212845 10.1073/pnas.95.26.15603 10.1093/nar/14.20.7873 10.1113/jphysiol.2002.035832 10.1016/S0014-5793(02)02918-6 10.1096/fj.09-131870 10.1038/306609a0 10.1096/fj.11-203026 10.1074/jbc.270.20.12109 10.1016/j.ghir.2008.05.001 10.1152/ajpendo.00408.2013 10.1210/en.2012-1992 10.1016/S0960-8966(00)00192-9 10.1111/j.1600-6143.2007.01927.x 10.1210/mend-4-6-899 10.1152/japplphysiol.01405.2005 10.1371/journal.pone.0045588 10.1089/rej.2007.0597 10.1210/en.2009-1217 10.1113/jphysiol.1988.sp017279 10.1371/journal.pone.0051152 10.1091/mbc.E08-12-1202 10.1152/japplphysiol.01308.2009 10.1055/s-2007-978697 10.1210/me.2004-0409 10.1054/ghir.2000.0182 10.1038/mt.2008.171 10.1210/mend-2-6-528 |
ContentType | Journal Article |
Copyright | Copyright American Physiological Society Apr 15, 2014 Copyright © 2014 the American Physiological Society 2014 American Physiological Society |
Copyright_xml | – notice: Copyright American Physiological Society Apr 15, 2014 – notice: Copyright © 2014 the American Physiological Society 2014 American Physiological Society |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7TS 7U7 C1K 7X8 7U9 H94 5PM |
DOI | 10.1152/ajpendo.00008.2014 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Physical Education Index Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic Virology and AIDS Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Toxicology Abstracts Calcium & Calcified Tissue Abstracts Physical Education Index Environmental Sciences and Pollution Management MEDLINE - Academic AIDS and Cancer Research Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | Toxicology Abstracts MEDLINE AIDS and Cancer Research Abstracts CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1522-1555 |
EndPage | E974 |
ExternalDocumentID | 3288104861 10_1152_ajpendo_00008_2014 24569593 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAMS NIH HHS grantid: R01 AR057363 – fundername: NIAMS NIH HHS grantid: AR-057363 – fundername: NIAMS NIH HHS grantid: AR-053461 |
GroupedDBID | --- 23M 2WC 39C 4.4 53G 5GY 5VS 6J9 AAFWJ ABJNI ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP BTFSW CGR CUY CVF DIK E3Z EBS ECM EIF EJD EMOBN F5P GX1 H13 ITBOX KQ8 NPM OK1 P2P P6G PQQKQ RAP RHF RHI RPL RPRKH TR2 W8F WH7 WOQ XSW YSK AAYXX CITATION 7QP 7TS 7U7 C1K 7X8 7U9 H94 5PM |
ID | FETCH-LOGICAL-c463t-6aab0ce31b74c12b2b2ec2bf16be83d6a6cc07882e689cd661b5604b4b94d57b3 |
ISSN | 0193-1849 |
IngestDate | Tue Sep 17 21:26:51 EDT 2024 Fri Oct 25 06:24:18 EDT 2024 Fri Oct 25 23:49:47 EDT 2024 Thu Oct 10 16:45:00 EDT 2024 Thu Sep 12 17:24:48 EDT 2024 Sat Sep 28 08:02:29 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | adeno-associated viral vectors IGF-I E-peptides skeletal muscle hypertrophy |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c463t-6aab0ce31b74c12b2b2ec2bf16be83d6a6cc07882e689cd661b5604b4b94d57b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://europepmc.org/articles/pmc3989742 |
PMID | 24569593 |
PQID | 1519620301 |
PQPubID | 48583 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3989742 proquest_miscellaneous_1534850334 proquest_miscellaneous_1517399024 proquest_journals_1519620301 crossref_primary_10_1152_ajpendo_00008_2014 pubmed_primary_24569593 |
PublicationCentury | 2000 |
PublicationDate | 2014-04-15 |
PublicationDateYYYYMMDD | 2014-04-15 |
PublicationDate_xml | – month: 04 year: 2014 text: 2014-04-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bethesda – name: Bethesda, MD |
PublicationTitle | American journal of physiology: endocrinology and metabolism |
PublicationTitleAlternate | Am J Physiol Endocrinol Metab |
PublicationYear | 2014 |
Publisher | American Physiological Society |
Publisher_xml | – name: American Physiological Society |
References | 6358902 - Nature. 1983 Dec 8-14;306(5943):609-11 3253447 - J Physiol. 1988 Oct;404:71-82 11297941 - Neuromuscul Disord. 2001 Apr;11(3):260-8 19661286 - FASEB J. 2009 Nov;23(11):3896-905 24371018 - J Appl Physiol (1985). 2014 Apr 1;116(7):797-806 23407283 - J Vis Exp. 2013;(71):e50036 8897022 - Endocr Rev. 1996 Oct;17(5):481-517 17531227 - FEBS Lett. 2007 Jun 12;581(14):2727-32 24253050 - Am J Physiol Endocrinol Metab. 2014 Jan 15;306(2):E150-6 23029120 - PLoS One. 2012;7(9):e45588 23407451 - Endocrinology. 2013 Mar;154(3):1215-24 17822355 - Rejuvenation Res. 2007 Sep;10(3):397-405 22649033 - FASEB J. 2012 Sep;26(9):3691-702 3453891 - Mol Endocrinol. 1987 Mar;1(3):243-8 16439513 - J Appl Physiol (1985). 2006 Jun;100(6):1778-84 12692175 - J Physiol. 2003 Jun 1;549(Pt 2):409-18 15576456 - Mol Endocrinol. 2005 Mar;19(3):711-21 19567392 - In Vivo. 2009 Jul-Aug;23(4):567-75 22125316 - FASEB J. 2012 Mar;26(3):1077-85 18571449 - Growth Horm IGF Res. 2009 Feb;19(1):12-23 9572822 - J Appl Physiol (1985). 1998 May;84(5):1716-22 11437469 - Growth Horm IGF Res. 2001 Feb;11(1):10-7 11827994 - J Clin Invest. 2002 Feb;109(3):347-55 12095637 - FEBS Lett. 2002 Jul 3;522(1-3):156-60 20130113 - Endocrinology. 2010 Mar;151(3):865-75 23251442 - PLoS One. 2012;7(12):e51152 10226780 - Horm Metab Res. 1999 Feb-Mar;31(2-3):43-9 8402901 - Cell. 1993 Oct 8;75(1):59-72 11175789 - Nat Genet. 2001 Feb;27(2):195-200 21807613 - J Physiol. 2011 Oct 1;589(Pt 19):4759-76 3774549 - Nucleic Acids Res. 1986 Oct 24;14(20):7873-82 18682697 - Mol Ther. 2008 Oct;16(10):1648-56 20133429 - J Appl Physiol (1985). 2010 May;108(5):1069-76 18396778 - In Vivo. 2008 Jan-Feb;22(1):27-35 3419435 - Mol Endocrinol. 1988 Jun;2(6):528-35 17267614 - Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1835-40 17845560 - Am J Transplant. 2007 Oct;7(10):2247-59 19605562 - Mol Biol Cell. 2009 Sep;20(17):3810-7 7744859 - J Biol Chem. 1995 May 19;270(20):12109-16 9861016 - Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15603-7 11485987 - Genes Dev. 2001 Aug 1;15(15):1926-34 2233747 - Mol Endocrinol. 1990 Jun;4(6):899-904 3312279 - J Clin Endocrinol Metab. 1987 Nov;65(5):868-75 2199752 - Med Sci Sports Exerc. 1990 Jun;22(3):304-11 B20 B42 B43 B22 B44 B23 B24 B25 B26 B28 B29 Philippou A (B38) 2008; 22 B30 B31 B10 B32 B11 Moorwood C (B33) 2013 B12 B34 B13 B14 B36 B15 B16 B17 B39 B18 B19 Florini JR (B21) 1996; 17 Liu JP (B27) 1993; 75 B1 B2 B3 B4 B5 Philippou A (B37) 2009; 23 B6 B7 B8 B9 Park S (B35) 2013 B40 B41 |
References_xml | – ident: B3 doi: 10.1073/pnas.0604893104 – ident: B19 doi: 10.1172/JCI0213503 – start-page: e50036 year: 2013 ident: B33 publication-title: J Vis Exp contributor: fullname: Moorwood C – ident: B39 doi: 10.1210/jcem-65-5-868 – ident: B4 doi: 10.1016/j.febslet.2007.05.030 – ident: B41 doi: 10.1210/mend-1-3-243 – ident: B20 doi: 10.1101/gad.908001 – ident: B40 doi: 10.1096/fj.11-192195 – ident: B34 doi: 10.1038/84839 – year: 2013 ident: B35 publication-title: J Appl Physiol (1985) contributor: fullname: Park S – ident: B1 doi: 10.1152/jappl.1998.84.5.1716 – ident: B2 doi: 10.1249/00005768-199006000-00006 – ident: B6 doi: 10.1113/jphysiol.2011.212845 – ident: B10 doi: 10.1073/pnas.95.26.15603 – ident: B11 doi: 10.1093/nar/14.20.7873 – ident: B25 doi: 10.1113/jphysiol.2002.035832 – ident: B44 doi: 10.1016/S0014-5793(02)02918-6 – ident: B12 doi: 10.1096/fj.09-131870 – ident: B26 doi: 10.1038/306609a0 – ident: B9 doi: 10.1096/fj.11-203026 – ident: B15 doi: 10.1074/jbc.270.20.12109 – ident: B42 doi: 10.1016/j.ghir.2008.05.001 – volume: 17 start-page: 481 year: 1996 ident: B21 publication-title: Endocr Rev contributor: fullname: Florini JR – ident: B22 doi: 10.1152/ajpendo.00408.2013 – ident: B18 doi: 10.1210/en.2012-1992 – ident: B29 doi: 10.1016/S0960-8966(00)00192-9 – ident: B32 doi: 10.1111/j.1600-6143.2007.01927.x – ident: B5 doi: 10.1210/mend-4-6-899 – ident: B7 doi: 10.1152/japplphysiol.01405.2005 – ident: B13 doi: 10.1371/journal.pone.0045588 – ident: B23 doi: 10.1089/rej.2007.0597 – volume: 75 start-page: 59 year: 1993 ident: B27 publication-title: Cell contributor: fullname: Liu JP – ident: B30 doi: 10.1210/en.2009-1217 – ident: B14 doi: 10.1113/jphysiol.1988.sp017279 – ident: B24 doi: 10.1371/journal.pone.0051152 – ident: B36 doi: 10.1091/mbc.E08-12-1202 – volume: 22 start-page: 27 year: 2008 ident: B38 publication-title: In Vivo contributor: fullname: Philippou A – ident: B8 doi: 10.1152/japplphysiol.01308.2009 – ident: B17 doi: 10.1055/s-2007-978697 – ident: B16 doi: 10.1210/me.2004-0409 – ident: B43 doi: 10.1054/ghir.2000.0182 – ident: B31 doi: 10.1038/mt.2008.171 – volume: 23 start-page: 567 year: 2009 ident: B37 publication-title: In Vivo contributor: fullname: Philippou A – ident: B28 doi: 10.1210/mend-2-6-528 |
SSID | ssj0007542 |
Score | 2.2675142 |
Snippet | Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | E965 |
SubjectTerms | 3T3 Cells Animals Cellular biology Dependovirus Gene Transfer Techniques Genetic Vectors Human growth Insulin-Like Growth Factor I - genetics Insulin-like growth factors Mice Mice, Inbred C57BL Muscle Strength - genetics Muscle, Skeletal - anatomy & histology Muscle, Skeletal - metabolism Musculoskeletal system Organ Size - genetics Peptide Fragments - genetics Phosphorylation Physiology Protein expression |
Title | Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24569593 https://www.proquest.com/docview/1519620301 https://search.proquest.com/docview/1517399024 https://search.proquest.com/docview/1534850334 https://pubmed.ncbi.nlm.nih.gov/PMC3989742 |
Volume | 306 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF5FRUK8IGg5AgUtEuIlMjS-_diiVCm05UpQ3yzv4SYksSNiSyT_mn_AzO76CEEVoEiWZa-8m53PszPrb2YIeRmCjksi4Vu-5KnlMtuxIltwC1ZmMJaTVHKBgcIXl_5w7L678q46nZ8t1lJZsNd888e4kv-RKlwDuWKU7D9Itn4oXIBzkC8cQcJw_CsZf51ieL38Ycismc7_oMjl1nw6k71rcLKLiSmq0zvrDawlsliEYmGhvbiCs9UMlh6MiVyUK-igtwB7usfKKs5RFQHI9JY_RpZk18WkbdLW33xaSSjUfomOg8HKP5nIQTllTbqnBfTH8nmVvlBtBwACNAPgRPLZurX9upxmyWYDLrhm9SIvp0bjR0P1_pLnw3VZA_0EJssUKZljEmEJk_C5vcHRV7wYHeLZiinAFaEaukKvIbW2t0YjxwJ_VStgadQ5uNpgMXltfe8c-S1ghy3tPYh03YrdZcXDNLXJNyxLnKuUl4oV6DaLaEUcuPwQn47Pz-PR4Gq0fVfbDHYY9jHLITjst2zQjaiU339qEtxjQWId4a__TBXn5dlvdrvftqV2HKTfeb4tw2l0j9w1Hg891vC9Tzoy2ycHx1lS5Is1fUXrCV_vk9sXhupxQNYK3LQBN81T2gY31eCmGtz0jDbgpjW4aQVuqsFNEdwUwE2TggK4qQE3PrwC9wMyPh2M3g4tUyfE4q7vFJafJOyIS6fPApf3bQY_yW2W9n0mQ0f4ic85WMKhLf0w4gIsUgZ2vstcFrnCC5jzkOxleSYfE8oj37aFYGkCpjoPolA6zBFSeFHqgKvBu6RXzXi81OlgYuVGe3Zs5BMr-cQony45rIQSm3dwFYOJDZ3gTkSXvKhvg1LHL3XwDuWlahOA5wD2801tHDdEEgK0eaTlXA8J2QyYcbxLgi0E1A0wqfz2nWw6UcnlnSiMAtd-cvPQn5I7zat6SPaK76V8BtZ5wZ4rPP8CPpXxPg |
link.rule.ids | 230,315,783,787,888,27936,27937 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Viral+expression+of+insulin-like+growth+factor+I+E-peptides+increases+skeletal+muscle+mass+but+at+the+expense+of+strength&rft.jtitle=American+journal+of+physiology%3A+endocrinology+and+metabolism&rft.au=Brisson%2C+Becky+K&rft.au=Spinazzola%2C+Janelle&rft.au=Park%2C+SooHyun&rft.au=Barton%2C+Elisabeth+R&rft.date=2014-04-15&rft.pub=American+Physiological+Society&rft.issn=0193-1849&rft.eissn=1522-1555&rft.volume=306&rft.issue=8&rft.spage=E965&rft_id=info:doi/10.1152%2Fajpendo.00008.2014&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3288104861 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0193-1849&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0193-1849&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0193-1849&client=summon |